ClinicalTrials.gg
RecruitingNCT06567847Updated Nov 12, 2026

Neurocognitive Exercises for Ankle Instability

An interventional study of Neurocognitive Enriched Exercise and Multimodal Exercise in Ankle Sprains, sponsored by Istanbul University - Cerrahpasa. Recruiting at 2 sites in Turkey (Türkiye). Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Istanbul University - Cerrahpasa · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Dec 2025; still recruiting 11 months later.
Updated Nov 12, 2026Now RecruitingSite recruiting status changed+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 38 studies in Ankle Injuries with a site in Turkey — 8 open to participants now, 11 under way, none of them phase 3. Ankle Injuries · Turkey.

Planned enrollment
17th of 26
36 · median 45
Started
2025
with 2 others
No phase
23 of 38
7 open now
Primary completion
2027-02
later than 8 of 10 live
Registered
26th of 38
by date
Lead sponsor
2 of 38
Istanbul University - Cerrahpasa

Among the 38 studies in Ankle Injuries with a site in Turkey, this one is the 17th largest by planned enrollment of the 26 interventional ones that give a count, is one of 3 that started in 2025, is one of 23 with no phase, reaches primary completion later than 8 of the 10 other live ones, and was the 26th registered.

Ankle Injuries

354 studies on the registry are indexed under Ankle Injuries; 77 are open to participants now.

Browse Ankle Injuries studies →

Open to participants now

8 of the 38 studies in Ankle Injuries with a site in Turkey are open now. Recruiting first, the newest first:

2 more — sign in →

All 8 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 47 Ankle Injuries studies recruiting now, 11 (23%) set no upper age limit and 33 (70%) stop at 75 or younger; 10 take children under 18; 8 take healthy volunteers.

This study: 18 Years to 55 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 38 studies in Ankle Injuries with a site in Turkey, or all of them as a file.
02

Study summary

In the general population, 19.0-26.6 per 1000 cases of ankle instability have been reported, while in the athletic population, the rate is 11.3 per 1000. Ankle instability also predisposes individuals to recurrent instability, leading to persistent symptoms. After ankle injuries, temporary increases in afferent activity, along with long-term deficits in somatosensory information from ligaments, may cause central neuroplasticity that affects sensorimotor function. This central neuroplasticity can lead to permanent dysfunctions in the affected limb, thereby increasing the likelihood of developing and maintaining chronic ankle instability (CAI). In addition to the association between impaired balance and reduced proprioception with CAI, it has been reported that the central nervous system may fail to manage joint stress due to its inability to discern load on the ligaments.

Impaired neurocognition has been linked to decreased performance and higher rates of re-injury. Deficiencies in neuromuscular control, motor learning, or other neurocognitive components related to an individual's performance and safety may affect the ability to respond appropriately in a dynamic environment. Any deficiencies in these neurocognitive processes can hinder the successful completion of tasks.

The aim of this study is to comparatively examine the effects of neurocognitively enriched rehabilitation versus traditional rehabilitation on re-injury risk, balance, and proprioception in individuals with a history of ankle instability.

Read the detailed description

Voluntary participants who have been diagnosed with lateral ankle instability will be included in the study. Signed voluntary consent will be obtained from participants. Participants will be divided into two groups. Study groups will be as follows: a) Neurocognitive Enriched Exercise, b) Multimodal Exercise.

03

Conditions studied

  • Ankle Sprains

Browse trials for

Keywords

  • Neuroplasticity
  • Reinjury
  • Chronic ankle instability
  • Physiotherapy
04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The documented unilateral ankle instability confirmed through clinical examinations (drawer test, talar tilt test) and MRI in cases requiring differential diagnosis.
  • A history of an initial ankle sprain occurring at least 6 months ago.
  • The presence of a recurrent sense of giving way that started at least 6 months ago and has been intermittently persistent.

Exclusion criteria

Exclusion Criteria:

  • Presence of a history of previous surgery in the lower extremity.
  • Identification of organic and non-organic lesions such as cartilage injuries, periarticular tendon tears, and impingement syndromes.
  • The existence of a fracture accompanying instability in the foot-ankle.
  • Presence of congenital deformities in the foot-ankle.
  • Diagnosis of talus osteochondral lesion.
  • Diagnosis of ankle arthritis.
  • Presence of medial ligament lesion.
  • Existence of peripheral neuropathy.
  • Presence of additional rheumatological diseases.
  • Regular moderate-level exercise for at least 3 days a week in the last 6 months.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
36 participants (estimated)

Study arms

  • Active comparator
    Neurocognitive Enriched Exercise

    Individuals with a diagnosis of lateral ankle instability who underwent supervised neurocognitive enriched exercise under the guidance of a physiotherapist for 8 weeks, 2 days a week.

    Other: Neurocognitive Enriched Exercise

  • Active comparator
    Multimodal Exercise

    Individuals with a diagnosis of lateral ankle instability who underwent supervised routine exercise under the guidance of a physiotherapist for 8 weeks, 2 days a week.

    Other: Multimodal Exercise

Interventions

  • OtherNeurocognitive Enriched Exercise

    An intervention planned, progressed, and conducted under the supervision of a physiotherapist, which enriches strengthening, balance, range of motion, stretching, and mobilization exercises with neurocognitive elements.

  • OtherMultimodal Exercise

    Supervised and progressively advanced interventions that include strengthening, balance, range of motion, stretching, and mobilization exercises.

06

What researchers measure

Primary outcomes

  1. Cumberland Ankle Instability Tool (CAIT)

    It is a 30-point, 9-item scale measuring the severity of functional ankle instability. Lower scores indicate functional ankle instability. The Minimal Clinically Important Difference for this valid and reliable scale is 3 points.

    Time frame: change from baseline at 6 months

  2. Surface Electromyography-maximum voluntary isometric contraction

    Electrode placements will be performed in accordance with the European Recommendations from Surface EMG for Non-Invasive Assessment of Muscles (SENIAM).

    Time frame: change from baseline at 6 months

  3. Surface Electromyography-muscles' normal functional activities

    Electrode placements will be performed in accordance with the European Recommendations from Surface EMG for Non-Invasive Assessment of Muscles (SENIAM).

    Time frame: change from baseline at 6 months

Secondary outcomes

  1. Ultrasonography

    The pennation angles of the peroneal, gastrocnemius, and tibialis anterior muscle groups will be evaluated and recorded using ultrasonographic imaging. The pennation angle will be defined as the angle between the muscle fascicle and the superficial aponeurosis.

    Time frame: 3 times for 24 weeks

  2. Numeric Pain Rating Scale

    Pain during activity in the ankle will be assessed with a pain NPRS, a numbered scale of 11 points. On this scale, "0" indicates no pain, and "10" indicates the most severe pain imaginable.

    Time frame: 3 times for 24 weeks

  3. Joint Range of Motion Evaluation

    During the assessments, three repeat measurements will be made using an electronic goniometer. For goniometric measurement, the pivot point will be placed on the lateral malleolus. The fixed arm will be kept parallel to the lateral midline of the fibula. The moving arm, on the other hand, will follow the lateral midline of the 5th metatarsal bone.

    Time frame: 3 times for 24 weeks

  4. Tampa Kinesiophoby Scoring

    It is a 17-item scale developed to assess the fear of movement/re-injury. The lowest possible score on the test is 17; the highest score is 68; and a score higher than 37 is an indicator of poor health outcomes.

    Time frame: 3 times for 24 weeks

  5. Star Excursion Test

    Physical performance that requires strength, flexibility, and proprioception is assessed through a dynamic test evaluating dynamic postural control and lower extremity injury risk associated with musculoskeletal injuries. The protocol of the test involves maintaining balance on the ipsilateral leg while reaching as far as possible with the contralateral leg.

    Time frame: 3 times for 24 weeks

  6. Single Leg Stance Test

    Participants' standing balance will be assessed. Initially, one foot will be positioned on a firm and flat surface with the entire lower extremity in full extension, while the other lower extremity is positioned with the hip and knee flexed at 90 degrees. With their eyes closed, participants will start the timing when the foot not being tested loses contact with the ground, and the timing will stop when they place their foot back on the ground or when there is a significant increase in body sway.

    Time frame: 3 times for 24 weeks

  7. The Side Hop Test

    It is a test that assesses the functional stability of patients. Patients will be asked to stand on one leg on the affected extremity. They will then be required to perform 10 jumps over two pre-determined strips that are spaced 30 cm apart.

    Time frame: 3 times for 24 weeks

  8. Global Rating of Change Scale-GRC

    It will be used to evaluate patient satisfaction. It is designed to determine the amount of improvement or worsening of the patient over time. In our study, GRC consisting of 5 levels between -2 and +2 value ranges (-2: I am much worse, -1: I am worse, 0: I am the same, 1: I am better, 2: I am much better) was preferred.

    Time frame: 2 times for 52 weeks

  9. Reproduction Test

    While the eyes of the individuals are closed, the ankle joints will be positioned and a goniometric measurement will be performed. Then, the patient will be brought to the starting position and asked to achieve the same movement. The difference between the two measurements will be recorded.

    Time frame: 3 times for 24 weeks

07

Study locations

2 of 2 sites recruiting
08

References and documents

Publications

  • Gribble PA, Bleakley CM, Caulfield BM, Docherty CL, Fourchet F, Fong DT, Hertel J, Hiller CE, Kaminski TW, McKeon PO, Refshauge KM, Verhagen EA, Vicenzino BT, Wikstrom EA, Delahunt E. Evidence review for the 2016 International Ankle Consortium consensus statement on the prevalence, impact and long-term consequences of lateral ankle sprains. Br J Sports Med. 2016 Dec;50(24):1496-1505. doi: 10.1136/bjsports-2016-096189. Epub 2016 Jun 3. PubMed 27259753 ↗
  • Owoeye OBA, Palacios-Derflingher LM, Emery CA. Prevention of Ankle Sprain Injuries in Youth Soccer and Basketball: Effectiveness of a Neuromuscular Training Program and Examining Risk Factors. Clin J Sport Med. 2018 Jul;28(4):325-331. doi: 10.1097/JSM.0000000000000462. PubMed 29864071 ↗
  • van Dijk CN, Vuurberg G. There is no such thing as a simple ankle sprain: clinical commentary on the 2016 International Ankle Consortium position statement. Br J Sports Med. 2017 Mar;51(6):485-486. doi: 10.1136/bjsports-2016-096733. Epub 2016 Oct 18. No abstract available. PubMed 27797735 ↗
  • Xue X, Ma T, Li Q, Song Y, Hua Y. Chronic ankle instability is associated with proprioception deficits: A systematic review and meta-analysis. J Sport Health Sci. 2021 Mar;10(2):182-191. doi: 10.1016/j.jshs.2020.09.014. Epub 2020 Oct 2. PubMed 33017672 ↗
  • Suttmiller AMB, McCann RS. Neural excitability of lower extremity musculature in individuals with and without chronic ankle instability: A systematic review and meta-analysis. J Electromyogr Kinesiol. 2020 Aug;53:102436. doi: 10.1016/j.jelekin.2020.102436. Epub 2020 Jun 1. PubMed 32505988 ↗
  • Needle AR, Lepley AS, Grooms DR. Central Nervous System Adaptation After Ligamentous Injury: a Summary of Theories, Evidence, and Clinical Interpretation. Sports Med. 2017 Jul;47(7):1271-1288. doi: 10.1007/s40279-016-0666-y. PubMed 28005191 ↗
  • Wilke J, Groneberg DA. Neurocognitive function and musculoskeletal injury risk in sports:A systematic review. J Sci Med Sport. 2022 Jan;25(1):41-45. doi: 10.1016/j.jsams.2021.07.002. Epub 2021 Jul 9. PubMed 34303619 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2025 (actual). Primary completion is estimated for Feb 2027, 14 months after the start.

Of 141 non-industry interventional studies with no phase under Ankle Injuries, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 31. This study's planned 14 months is above that.

Counting every sponsor, half of 144 studies reached it within 9 months; a quarter within 4 and three quarters within 31.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 12, 2026: start Nov 2025 → Dec 2025, primary completion Nov 2027 → Feb 2027 and completion Feb 2028 → Jun 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 20, 2024
First posted
Aug 23, 2024
StartActual
Dec 18, 2025was Nov 2025
Primary completionEst.
Feb 2027was Nov 2027
CompletionEst.
Jun 2027was Feb 2028
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 12, 2026
Sites
1 site added. Acibadem Mehmet Ali Aydinlar University is now Recruiting
Show site
  • Istanbul University-Cerrahpaşa · Istanbul, Turkey (Türkiye)
Nov 12, 2026
Start date
Nov 2025→Dec 18, 2025 (actual)
Nov 12, 2026
Primary completion
Nov 2027→Feb 2027
Nov 12, 2026
Study completion
Feb 2028→Jun 2027
Nov 12, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Acibadem Mehmet Ali Aydinlar University · Istanbul, Turkey (Türkiye)Contact added t•••@acibadem.edu.tr · •••4444Contact added (no phone or email listed)Contact added (no phone or email listed)
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Not yet recruiting→Recruiting
    1 site added. Acibadem Mehmet Ali Aydinlar University is now Recruiting
    Show site
    • Istanbul University-Cerrahpaşa · Istanbul, Turkey (Türkiye)
    Start date Nov 2025→Dec 18, 2025 (now actual)
    Primary completion Nov 2027→Feb 2027
    Study completion Feb 2028→Jun 2027
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Acibadem Mehmet Ali Aydinlar University · Istanbul, Turkey (Türkiye)Contact added t•••@acibadem.edu.tr · •••4444Contact added (no phone or email listed)Contact added (no phone or email listed)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06567847
Collaborators
Bezmialem Vakif University, Acıbadem Atunizade Hospital
Responsible party
Aysenur Erekdag (Principal Investigator, Istanbul University - Cerrahpasa) — Principal investigator
First posted
Aug 23, 2024
Start date
Dec 18, 2025
Primary completion
Feb 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Nov 12, 2026

Study contacts

Ayşenur Erekdağ, MSc
Contact
aysenurerekdag@gmail.com
+902124012600 ext. 4639
Ipek Yeldan, PhD
Contact
ipekyeldan@gmail.com
+902128663700
Ayşenur Erekdağ, MSc
principal investigator · Bezmialem Vakif University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion